Companies › Journal of Psychedelic Psychiatry

Journal of Psychedelic Psychiatry

Company Healthcare

Journal of Psychedelic Psychiatry is listed as a company in Healthcare. It has filed 1 comment letter on 1 proposed federal rule in 2026, most often with the Drug Enforcement Administration.

Type
Company
Industry
Healthcare
Comment letters
1
Rules commented on
1
First letter
2026-09-28
Latest letter
2026-09-28
Agencies most often
Drug Enforcement Administration (1)

Activity by year

20261

Letters

2026

Schedules of Controlled Substances: Placement of 4-Hydroxy-N,N-Diisopropyltryptamine (4-OH-DiPT), 5-Methoxy-alpha-Methyltryptamine (5-MeO-AMT), 5-Methoxy-N-Methyl-N-Isopropyltryptamine (5-MeO-MiPT), 5-Methoxy-N,N-Diethyltryptamine (5-MeO-DET), and N,N-Diisopropyltryptamine (DiPT) Into Schedule I

DEA-2026-1585Justice Department, Drug Enforcement Administration · filed 2026-09-28
Read the letter ↗